Clinical trial
Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler…
NCT00123201 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00123201 |
|---|---|
| Title | Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache |
| Official title | A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Efficacy, Safety and Tolerability Study of Dronabinol MDI in the Acute Treatment of Migraine Headache |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Collaborators | Nektar Therapeutics Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine With Aura, Migraine Without Aura |
| Intervention type | Drug |
| Interventions | Dronabinol MDI |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Jul 22, 2005 |
| Last update posted | Jan 16, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: